SPBC13G1.14c Antibody

What is SPBC13G1.14c protein in Schizosaccharomyces pombe?

SPBC13G1.14c refers to a specific gene locus in the fission yeast Schizosaccharomyces pombe. The protein encoded by this gene has the UniProt accession number Q1MTR2. This protein is studied in the context of S. pombe biology, which serves as an important model organism for understanding eukaryotic cell processes, particularly cell division and chromosome dynamics. While the specific function may still be under investigation, its study contributes to our understanding of conserved cellular mechanisms in eukaryotes.

How is the SPBC13G1.14c Antibody generated?

The SPBC13G1.14c Antibody is a polyclonal antibody raised in rabbits against a recombinant Schizosaccharomyces pombe (strain 972/ATCC 24843) SPBC13G1.14c protein . The generation process involves immunizing rabbits with the purified recombinant protein, collecting serum after a sufficient immune response, and purifying the antibodies using antigen affinity purification methods . This approach ensures the final antibody preparation contains a diverse population of antibodies that recognize different epitopes on the target protein, providing robust detection capabilities.

What are the optimal storage conditions for SPBC13G1.14c Antibody?

According to the product information, SPBC13G1.14c Antibody should be stored at -20°C or -80°C upon receipt . The antibody is provided in liquid form with a storage buffer containing 0.03% Proclin 300 as a preservative, 50% Glycerol, and 0.01M PBS at pH 7.4 . Repeated freeze-thaw cycles should be avoided as they can lead to denaturation and loss of antibody activity. For optimal preservation of activity, it is recommended to aliquot the antibody into smaller volumes before freezing to minimize the number of freeze-thaw cycles.

What applications is SPBC13G1.14c Antibody validated for?

The SPBC13G1.14c Antibody has been validated for ELISA (Enzyme-Linked Immunosorbent Assay) and Western Blot (WB) applications . These validations ensure that the antibody can successfully identify the target antigen in these specific experimental contexts. The antibody is designated "for research use only" and not intended for diagnostic or therapeutic applications . Researchers should perform additional validation when adapting the antibody for applications beyond those specifically listed in the technical documentation.

How do I optimize Western blot protocols for SPBC13G1.14c Antibody?

Optimizing Western blot protocols for SPBC13G1.14c Antibody requires systematic testing of several parameters:

Sample Preparation:

• Extract proteins from S. pombe cells in mid-logarithmic growth phase

• Use a lysis buffer containing protease inhibitors to prevent protein degradation

• Determine protein concentration using Bradford or BCA assay

Electrophoresis and Transfer:

• Load 20-50 μg of total protein per lane

• Use fresh transfer buffer and optimize transfer time (typically 1-2 hours at 100V)

• Consider using PVDF membranes for higher protein binding capacity

Antibody Incubation:

• Start with a 1:1000 dilution of the primary antibody

• Incubate membranes overnight at 4°C for optimal binding

• Use a compatible secondary antibody (anti-rabbit IgG) at 1:5000-1:10000 dilution

Detection Optimization:

• Test both chemiluminescent and fluorescent detection methods

• For weak signals, consider extended exposure times or signal enhancement reagents

• Include positive and negative controls to validate specificity

A typical titration experiment comparing different antibody dilutions might yield results as shown in this table:

What controls should I use when working with SPBC13G1.14c Antibody?

Implementing appropriate controls is crucial for interpreting results with SPBC13G1.14c Antibody:

Positive Controls:

• Wild-type S. pombe cell lysate expressing SPBC13G1.14c

• Recombinant SPBC13G1.14c protein (if available)

Negative Controls:

• SPBC13G1.14c knockout/deletion strain lysate

• Non-related species lysate (e.g., S. cerevisiae)

• Pre-immune serum control

Procedural Controls:

• Secondary antibody-only control to assess non-specific binding

• Loading control (e.g., anti-tubulin antibody) to normalize protein amounts

• Peptide competition assay where the antibody is pre-incubated with excess antigen

How do I determine the optimal dilution for SPBC13G1.14c Antibody in my experiments?

Determining the optimal dilution for SPBC13G1.14c Antibody requires a systematic titration approach:

For Western Blotting:

• Prepare identical membrane strips with the same samples

• Test a range of antibody dilutions (e.g., 1:500, 1:1000, 1:2000, 1:5000)

• Process all strips identically (same blocking, washing, secondary antibody)

• Analyze signal intensity and background for each dilution

• Select the dilution that provides the best signal-to-noise ratio

For ELISA:

• Coat plate wells with serial dilutions of the antigen

• For each antigen dilution, test multiple antibody dilutions

• Create a two-dimensional titration matrix

• Measure absorbance values and calculate signal-to-noise ratios

• Determine the optimal working range where signal correlates linearly with antigen concentration

Different applications typically require different dilutions, and batch-to-batch variations may necessitate re-optimization. The product documentation states that optimal dilutions should be determined by each laboratory for each application .

Can I apply machine learning approaches to predict SPBC13G1.14c Antibody specificity?

Recent advances in computational approaches for antibody research suggest the potential for applying machine learning to predict antibody specificity:

Model Training Considerations:

• Deep learning models can be trained to distinguish between antibodies to different targets based on sequence features

• Biophysics-informed models can disentangle multiple binding modes associated with specific ligands

• Training requires large datasets of antibody sequences with known specificities

Practical Implementation:

• Extract sequence features from SPBC13G1.14c Antibody (if sequence available)

• Apply trained models to predict:

  • Potential cross-reactivity with related proteins

  • Epitope regions on the target protein

  • Binding affinity estimates

Validation Requirements:

• Computational predictions should be validated experimentally

• Compare predicted specificity with actual binding profiles

• Use predictions to guide experimental design rather than replace validation

Research demonstrates that deep learning models can accurately distinguish between antibodies to different targets, such as SARS-CoV-2 spike protein versus influenza hemagglutinin protein . Similar approaches could potentially be applied to predict SPBC13G1.14c Antibody binding characteristics.

Why am I getting high background when using SPBC13G1.14c Antibody in immunostaining?

High background in immunostaining with SPBC13G1.14c Antibody can stem from multiple sources:

Common Causes and Solutions:

• Insufficient Blocking:

  • Extend blocking time to 2 hours at room temperature

  • Try different blocking agents (BSA, normal serum, commercial blockers)

  • Increase blocking agent concentration to 5-10%

• Antibody Concentration Issues:

  • Further dilute primary antibody (try 1:2000 instead of 1:1000)

  • Reduce secondary antibody concentration

  • Perform sequential dilution series to identify optimal concentration

• Fixation Problems:

  • Test different fixatives (4% PFA, methanol, or combinations)

  • Optimize fixation time to preserve epitope accessibility

  • Include permeabilization step with 0.1-0.5% Triton X-100

• Non-specific Binding:

  • Pre-adsorb antibody with acetone powder from a different species

  • Add 0.1-0.2% Tween-20 to antibody dilution buffer

  • Increase salt concentration in wash buffers (up to 500 mM NaCl)

Implementing a systematic troubleshooting approach by changing one variable at a time will help identify the source of high background and improve experimental outcomes.

How do I validate the specificity of SPBC13G1.14c Antibody in my experiments?

Validating antibody specificity is crucial for experimental rigor and reproducibility:

Genetic Validation:

• Test antibody reactivity in wild-type versus SPBC13G1.14c knockout/deletion strains

• Use CRISPR/Cas9-edited strains with epitope tags to confirm co-localization

• Employ siRNA/RNAi knockdown to demonstrate signal reduction correlating with protein depletion

Biochemical Validation:

• Perform peptide competition assays where excessive antigen blocks specific binding

• Analyze reactivity against recombinant full-length protein and fragments

• Compare reactivity pattern with antibodies against different epitopes of the same protein

Analytical Validation:

• Mass spectrometry analysis of immunoprecipitated material

• Correlation of signal with protein expression levels in different conditions

• Multi-method confirmation (e.g., if Western blot shows a band of expected size, confirm by IP-MS)

Methodological Controls:

• Include secondary-only controls

• Test cross-reactivity with related proteins

• Analyze non-specific binding to common contaminants

What should I do if SPBC13G1.14c Antibody shows reduced activity after storage?

Antibody activity can decrease during storage due to various factors. Here's a systematic approach to address and prevent this issue:

Immediate Troubleshooting:

• Centrifuge the antibody (10,000g for 5 minutes) to remove any aggregates

• Verify appearance – cloudiness may indicate denaturation

• Test activity at multiple dilutions – reduced activity may be compensated by using higher concentration

Preventive Measures:

• Proper aliquoting:

  • Divide antibody into single-use aliquots (10-20 μL)

  • Use screw-cap microcentrifuge tubes with O-rings to prevent evaporation

  • Label with date, concentrations, and freeze/thaw count

• Optimal storage conditions:

  • Store at -80°C for long-term stability as recommended

  • Keep working aliquot at 4°C for up to 2 weeks

  • Avoid storing antibody at diluted concentrations

• Handling precautions:

  • Never vortex antibodies (gentle mixing only)

  • Allow to warm to room temperature before opening to prevent condensation

  • Use low-retention pipette tips to minimize loss

The product documentation specifies that the antibody should maintain stability for 12 months from date of receipt at -20°C to -70°C as supplied, 1 month at 2-8°C under sterile conditions after reconstitution, and 6 months at -20°C to -70°C under sterile conditions after reconstitution .

How can I reduce non-specific binding when using SPBC13G1.14c Antibody?

Non-specific binding is a common challenge that can be addressed through multiple approaches:

Buffer Optimization:

• Increase blocking agent concentration (5% BSA or milk)

• Add 0.1-0.5% Tween-20 to washing and incubation buffers

• Include 0.1-0.5 M NaCl in washing buffers to disrupt ionic interactions

• Add 0.1% SDS to reduce hydrophobic interactions

Antibody Handling:

• Pre-adsorb antibody against cell/tissue extracts lacking the target

• Optimize antibody concentration through titration experiments

• Reduce incubation time or temperature

Sample Preparation:

• Extensive pre-clearing of lysates with Protein A/G beads

• Use detergent-compatible extraction methods

• Implement additional purification steps for complex samples

Protocol Modifications:

• Extend washing steps (increase number and duration)

• Use more stringent washing conditions progressively

• Implement a two-step detection system with enhanced specificity

The following table shows common non-specific binding issues and their solutions:

How can SPBC13G1.14c Antibody be used to study protein-protein interactions?

SPBC13G1.14c Antibody can be leveraged for studying protein-protein interactions through several advanced techniques:

Co-Immunoprecipitation (Co-IP):

• Optimize IP conditions for SPBC13G1.14c Antibody

• Use physiological buffer conditions to preserve native interactions

• Analyze co-precipitated proteins by:

  • Western blotting for suspected interaction partners

  • Mass spectrometry for unbiased identification

  • Targeted proteomics for quantitative assessment

Proximity Ligation Assay (PLA):

• Use SPBC13G1.14c Antibody with antibodies against suspected interaction partners

• The technique generates fluorescent spots only when proteins are within 40 nm

• Provides spatial information about interactions within cells

• Quantify interaction frequency under different conditions

Immunofluorescence Co-localization:

• Perform dual immunofluorescence with SPBC13G1.14c Antibody and partner protein antibodies

• Analyze co-localization using confocal microscopy

• Calculate Pearson's correlation coefficient or Manders' overlap coefficient

• Perform time-lapse imaging to detect dynamic interactions

Data interpretation should consider factors like antibody interference with binding sites, transient interactions, and subcellular compartmentalization. These approaches can help elucidate the functional role of SPBC13G1.14c in cellular processes.

How can I use SPBC13G1.14c Antibody for studying post-translational modifications?

Investigating post-translational modifications (PTMs) of SPBC13G1.14c requires specialized approaches:

Modification-Specific Detection:

• Immunoprecipitate SPBC13G1.14c using the antibody

• Probe with modification-specific antibodies (phospho-, acetyl-, ubiquitin-specific)

• Alternatively, analyze by mass spectrometry to identify PTMs

• Compare modification patterns under different cellular conditions

Functional Analysis:

• Correlate modifications with protein activity or localization

• Treat cells with modifying enzyme inhibitors to assess effects on SPBC13G1.14c

• Create mutant forms of the protein where modification sites are altered

• Compare wild-type and mutant protein behavior

Kinetics Studies:

• Perform time-course experiments following cell stimulation

• Track the appearance and disappearance of specific modifications

• Correlate with cellular events or cell cycle phases

• Identify the enzymes responsible for adding/removing modifications

When studying PTMs, it's crucial to consider whether the antibody's epitope might be masked by certain modifications, potentially leading to false-negative results in some experimental conditions.

How can I use SPBC13G1.14c Antibody in studies of cell cycle regulation in fission yeast?

Fission yeast (S. pombe) is a powerful model for cell cycle studies, and SPBC13G1.14c Antibody can be applied in several sophisticated approaches:

Cell Cycle-Synchronized Analysis:

• Synchronize cells using:

  • Temperature-sensitive cdc mutants

  • Nitrogen starvation and release

  • Lactose gradient centrifugation

• Collect samples at defined cell cycle stages

• Analyze SPBC13G1.14c protein levels, localization, and modifications

• Correlate changes with cell cycle markers (e.g., Cdc13, Cdc2 activity)

Genetic Interaction Studies:

• Examine SPBC13G1.14c in wild-type and mutant backgrounds

• Analyze synthetic lethal or enhancing interactions

• Determine epistatic relationships with known cell cycle regulators

• Map SPBC13G1.14c function within regulatory networks

Localization Dynamics:

• Track SPBC13G1.14c localization throughout the cell cycle

• Co-stain with markers for specific subcellular structures

• Analyze relocalization in response to cell cycle checkpoints

• Quantify nuclear/cytoplasmic distribution ratios

Results might be analyzed in a cell cycle phase-specific manner, creating a comprehensive profile of SPBC13G1.14c behavior throughout the cell division cycle. This approach can provide insights into the protein's functional role in normal cell cycle progression.

What bioinformatic approaches can predict epitopes recognized by SPBC13G1.14c Antibody?

Computational methods can help identify potential epitopes recognized by the antibody:

Sequence-Based Prediction:

• Analyze the SPBC13G1.14c protein sequence for:

  • Hydrophilicity profiles

  • Surface accessibility prediction

  • Antigenic propensity scores

  • Secondary structure elements

• Apply epitope prediction algorithms (BepiPred, DiscoTope, etc.)

• Identify linear and conformational epitope candidates

Structural Analysis:

• Use homology modeling to predict SPBC13G1.14c structure if crystal structure unavailable

• Identify surface-exposed regions as potential epitopes

• Calculate electrostatic properties and solvent accessibility

• Identify regions with high B-factors (flexibility) which often make good epitopes

Integration with Experimental Data:

• Combine predictions with peptide mapping experiments

• Use competition assays to test predicted epitopes

• Create site-directed mutations in predicted epitope regions and test binding

• Compare with known epitopes of related proteins

Recent advances in machine learning approaches have significantly improved epitope prediction accuracy. As demonstrated in search result , biophysics-informed models can be trained on experimentally selected antibodies to predict binding modes associated with specific ligands, which could be applied to better understand SPBC13G1.14c Antibody binding properties.

How does SPBC13G1.14c Antibody compare with other S. pombe protein antibodies?

When comparing antibodies against different S. pombe proteins, several factors should be considered:

Technical Characteristics:

• Antibody type (polyclonal vs. monoclonal)

• Host species (rabbit, mouse, etc.)

• Purification method (affinity purification vs. whole serum)

• Validated applications (WB, IF, IP, etc.)

Performance Metrics:

• Sensitivity (minimum detectable protein amount)

• Specificity (cross-reactivity with related proteins)

• Background levels in different applications

• Reproducibility across different experimental conditions

Experimental Considerations:

• Compatibility with different fixation methods

• Performance in different buffer systems

• Stability and storage requirements

• Batch-to-batch consistency

The polyclonal nature of SPBC13G1.14c Antibody provides advantages in terms of recognizing multiple epitopes but may have different specificity characteristics compared to monoclonal antibodies against other S. pombe proteins. When designing multi-protein studies, these differences should be accounted for in experimental design and data interpretation.

How can I integrate findings from SPBC13G1.14c Antibody studies with public datasets?

Integrating antibody-based findings with public datasets enhances research depth and impact:

Data Integration Approaches:

• Compare protein expression patterns with transcriptomic data

• Correlate protein localization with ChIP-seq or Hi-C data

• Integrate protein interaction findings with published interactome datasets

• Connect phenotypic observations with genetic screening datasets

Public Resources:

• PomBase for S. pombe-specific genomic and proteomic data

• Gene Expression Omnibus (GEO) for transcriptomic datasets

• ProteomeXchange for mass spectrometry data

• BioGRID for protein-protein interaction networks

Integration Methodology:

• Normalize data across different platforms

• Apply statistical methods to identify significant correlations

• Use visualization tools to identify patterns

• Implement machine learning approaches for complex data integration

This integrative approach places antibody-based observations in a broader biological context and can reveal functional relationships not evident from single-technique studies.